CMS, the government's lead agency in regulating how thousands of clinical laboratories reliably conduct testing on human specimens, is urging state health officials to ensure that labs follow Centers for Disease Control and Prevention (CDC) guidelines in specimen collection to stop the potential spread of Ebola -- and hew to safety mandates and guidelines including those issued by the Occupational Safety and Health Administration as part of infection control. CMS is also part of the regulatory regime over clinical lab...